A prospective, multicenter and cohort study on avoid recurrence in adenomyosis after conservative surgery using various drugs

Trial Profile

A prospective, multicenter and cohort study on avoid recurrence in adenomyosis after conservative surgery using various drugs

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Aug 2018

At a glance

  • Drugs Triptorelin (Primary)
  • Indications Uterine cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jul 2018 Planned number of patients changed from 400 to 1128.
    • 28 Jul 2018 Planned End Date changed from 30 Sep 2020 to 22 May 2021.
    • 17 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top